Prab: CSV import

2025-04-05T13:35:15Z

CSV import

← Older revision		Revision as of 13:35, 5 April 2025
Line 1:		Line 1:
	[[File:Morbus_Fabry_Cornea_verticillata_01.jpg\|Morbus Fabry Cornea verticillata 01\|thumb]] '''Cornea verticillata''', also known as vortex keratopathy, is a condition characterized by the accumulation of lipid or other substances in the corneal epithelium, leading to a distinctive whorl-like pattern on the cornea. This condition can be associated with various systemic diseases and medications, and while it primarily affects the cornea's appearance, it rarely impacts vision significantly.		{{SI}}
			{{Infobox medical condition
			\| name = Cornea verticillata
			\| image = [[File:Morbus_Fabry_Cornea_verticillata_01.jpg\|left\|thumb\|Cornea verticillata as seen in a patient with Fabry disease]]
			\| caption = Cornea verticillata as seen in a patient with [[Fabry disease]]
			\| synonyms = Vortex keratopathy, whorl keratopathy
			\| field = [[Ophthalmology]]
			\| symptoms = Whorl-like corneal deposits
			\| complications = Usually asymptomatic, but may indicate systemic disease
			\| onset = Can occur at any age
			\| duration = Persistent
			\| causes = [[Fabry disease]], certain medications (e.g., [[amiodarone]], [[chloroquine]], [[hydroxychloroquine]])
			\| risks = Genetic predisposition, medication use
			\| diagnosis = [[Slit lamp]] examination
			\| differential = [[Corneal dystrophy]], other causes of corneal deposits
			\| treatment = Address underlying cause, discontinue causative medication if possible
			\| prognosis = Good, if underlying cause is managed
			\| frequency = Rare
			}}
			[[File:Morbus_Fabry_Cornea_verticillata_01.jpg\|Morbus Fabry Cornea verticillata 01\|left\|thumb]] '''Cornea verticillata''', also known as vortex keratopathy, is a condition characterized by the accumulation of lipid or other substances in the corneal epithelium, leading to a distinctive whorl-like pattern on the cornea. This condition can be associated with various systemic diseases and medications, and while it primarily affects the cornea's appearance, it rarely impacts vision significantly.
	==Causes and Associations==		==Causes and Associations==
	Cornea verticillata is most commonly associated with the use of certain medications, particularly [[Amiodarone]], an antiarrhythmic agent used to treat various types of cardiac arrhythmias. Other drugs that have been linked to this condition include chloroquine, hydroxychloroquine, indomethacin, tamoxifen, and fabry disease, a genetic disorder. In the case of Fabry disease, cornea verticillata is considered a hallmark sign and can be an important clue in the diagnosis of this condition.		Cornea verticillata is most commonly associated with the use of certain medications, particularly [[Amiodarone]], an antiarrhythmic agent used to treat various types of cardiac arrhythmias. Other drugs that have been linked to this condition include chloroquine, hydroxychloroquine, indomethacin, tamoxifen, and fabry disease, a genetic disorder. In the case of Fabry disease, cornea verticillata is considered a hallmark sign and can be an important clue in the diagnosis of this condition.

	==Clinical Presentation==		==Clinical Presentation==
	Patients with cornea verticillata typically present with a bilateral, symmetric whorl-like pattern of corneal deposits that originate from the central or paracentral cornea and radiate outward. These deposits are best visualized with slit-lamp examination, a common ophthalmologic diagnostic tool. Despite the apparent changes in the cornea, most patients remain asymptomatic, with no significant impact on visual acuity. However, in rare cases, patients may report slight blurring of vision or halos around lights.		Patients with cornea verticillata typically present with a bilateral, symmetric whorl-like pattern of corneal deposits that originate from the central or paracentral cornea and radiate outward. These deposits are best visualized with slit-lamp examination, a common ophthalmologic diagnostic tool. Despite the apparent changes in the cornea, most patients remain asymptomatic, with no significant impact on visual acuity. However, in rare cases, patients may report slight blurring of vision or halos around lights.

	==Diagnosis==		==Diagnosis==
	The diagnosis of cornea verticillata is primarily clinical, based on the characteristic appearance of the corneal deposits during slit-lamp examination. Additional tests are generally not necessary but may be conducted to investigate potential underlying causes, such as Fabry disease or adverse effects from medication use.		The diagnosis of cornea verticillata is primarily clinical, based on the characteristic appearance of the corneal deposits during slit-lamp examination. Additional tests are generally not necessary but may be conducted to investigate potential underlying causes, such as Fabry disease or adverse effects from medication use.

	==Management and Treatment==		==Management and Treatment==
	Management of cornea verticillata focuses on monitoring the condition and addressing the underlying cause. If the corneal deposits are linked to medication use, discontinuation or substitution of the medication, under the guidance of a healthcare professional, may lead to the resolution of the deposits. However, this decision must be carefully weighed against the benefits of the medication for the underlying condition. In cases associated with Fabry disease, enzyme replacement therapy may help in reducing corneal deposits.		Management of cornea verticillata focuses on monitoring the condition and addressing the underlying cause. If the corneal deposits are linked to medication use, discontinuation or substitution of the medication, under the guidance of a healthcare professional, may lead to the resolution of the deposits. However, this decision must be carefully weighed against the benefits of the medication for the underlying condition. In cases associated with Fabry disease, enzyme replacement therapy may help in reducing corneal deposits.

	==Prognosis==		==Prognosis==
	The prognosis for patients with cornea verticillata is generally good, as the condition rarely affects vision. However, monitoring is essential to ensure that any potential underlying diseases are managed appropriately.		The prognosis for patients with cornea verticillata is generally good, as the condition rarely affects vision. However, monitoring is essential to ensure that any potential underlying diseases are managed appropriately.

	[[Category:Eye diseases]]		[[Category:Eye diseases]]
	[[Category:Corneal disorders]]		[[Category:Corneal disorders]]

	{{medicine-stub}}		{{medicine-stub}}

Prab: CSV import

2024-04-24T01:10:16Z

CSV import

New page

[[File:Morbus_Fabry_Cornea_verticillata_01.jpg|Morbus Fabry Cornea verticillata 01|thumb]] '''Cornea verticillata''', also known as vortex keratopathy, is a condition characterized by the accumulation of lipid or other substances in the corneal epithelium, leading to a distinctive whorl-like pattern on the cornea. This condition can be associated with various systemic diseases and medications, and while it primarily affects the cornea's appearance, it rarely impacts vision significantly.

==Causes and Associations==
Cornea verticillata is most commonly associated with the use of certain medications, particularly [[Amiodarone]], an antiarrhythmic agent used to treat various types of cardiac arrhythmias. Other drugs that have been linked to this condition include chloroquine, hydroxychloroquine, indomethacin, tamoxifen, and fabry disease, a genetic disorder. In the case of Fabry disease, cornea verticillata is considered a hallmark sign and can be an important clue in the diagnosis of this condition.

==Clinical Presentation==
Patients with cornea verticillata typically present with a bilateral, symmetric whorl-like pattern of corneal deposits that originate from the central or paracentral cornea and radiate outward. These deposits are best visualized with slit-lamp examination, a common ophthalmologic diagnostic tool. Despite the apparent changes in the cornea, most patients remain asymptomatic, with no significant impact on visual acuity. However, in rare cases, patients may report slight blurring of vision or halos around lights.

==Diagnosis==
The diagnosis of cornea verticillata is primarily clinical, based on the characteristic appearance of the corneal deposits during slit-lamp examination. Additional tests are generally not necessary but may be conducted to investigate potential underlying causes, such as Fabry disease or adverse effects from medication use.

==Management and Treatment==
Management of cornea verticillata focuses on monitoring the condition and addressing the underlying cause. If the corneal deposits are linked to medication use, discontinuation or substitution of the medication, under the guidance of a healthcare professional, may lead to the resolution of the deposits. However, this decision must be carefully weighed against the benefits of the medication for the underlying condition. In cases associated with Fabry disease, enzyme replacement therapy may help in reducing corneal deposits.

==Prognosis==
The prognosis for patients with cornea verticillata is generally good, as the condition rarely affects vision. However, monitoring is essential to ensure that any potential underlying diseases are managed appropriately.

[[Category:Eye diseases]]
[[Category:Corneal disorders]]

{{medicine-stub}}

Cornea verticillata - Revision history

Prab: CSV import

Prab: CSV import